Acute effects of MitoQ on vascular endothelial function are influenced by cardiorespiratory fitness and baseline FMD in middle‐aged and older adults
The Journal of Physiology · 2024
DOI: 10.1113/jp285636 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Physiology, 2024. Verfasst von Nicholas A Carlini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Exercise Physiology, Human Performance Laboratory, Ball State University, Muncie, Indiana, USA. Hauptthemen laut MEDLINE: Ubiquinone, Endothelium, Vascular, Cardiorespiratory Fitness, Organophosphorus Compounds. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: ASPIRE, Ball State University.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
A key mechanism promoting vascular endothelial dysfunction is mitochondrial‐derived reactive oxygen species (mtROS). Aerobic exercise preserves endothelial function in preclinical models by lowering mtROS. However, the effects of mtROS on endothelial function in exercising and non‐exercising adults is limited. In a double‐blind, randomized, placebo‐controlled crossover study design 23 (10 M/13 F, age 62.1 ± 11.5 years) middle‐aged and older (MA/O, ≥45 years) adults were divided into two groups: exercisers (EX, n = 11) and non‐exercisers (NEX, n = 12). All participants had endothelial function (brachial artery flow‐mediated dilatation, FMD BA ) measured before and ∼1 h after mitoquinone mesylate (MitoQ) (single dose, 80 mg) and placebo supplementation. A two‐way repeated measures ANOVA was used to determine the effects of MitoQ and placebo on FMD BA . Pearson correlations assessed the association between the change in FMD BA with MitoQ and baseline FMD BA and cardiorespiratory fitness (CRF). Compared with placebo, MitoQ increased FMD BA in NEX by + 2.1% (MitoQ pre: 4.9 ± 0.4 vs . post: 7.0 ± 0.4 %, P = 0.004, interaction) but not in EX ( P = 0.695, interaction). MitoQ also increased endothelial function in adults with a FMD BA 6% ( P = 0.855, interaction). Baseline FMD BA and CRF were correlated (r = 0.44, P = 0.037), whereas the change in FMD BA with MitoQ was inversely correlated with CRF (r = ‐0.66, P < 0.001) and baseline FMD BA (r = ‐0.73, P < 0.0001). The relationship between the change in FMD BA and baseline FMD BA remained correlated after adjusting for CRF (r = ‐0.55, P = 0.007). These data demonstrate that MitoQ acutely improves FMD BA in NEX and EX adults who have a baseline FMD BA
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Exercise Physiology, Human Performance Laboratory, Ball State University, Muncie, Indiana, USA.
- DeBusk College of Osteopathic Medicine, Lincoln Memorial University, Harrogate, Tennessee, USA.
ORCID-Profile: Nicholas A Carlini
Förderung
- ASPIRE, Ball State University
Zitieren
APA
Carlini, N. A., Harber, M. P., & Fleenor, B. S. (2024). Acute effects of MitoQ on vascular endothelial function are influenced by cardiorespiratory fitness and baseline FMD in middle‐aged and older adults. The Journal of Physiology. https://doi.org/10.1113/jp285636
Vancouver
Carlini NA, Harber MP, Fleenor BS. Acute effects of MitoQ on vascular endothelial function are influenced by cardiorespiratory fitness and baseline FMD in middle‐aged and older adults. The Journal of Physiology. 2024. doi:10.1113/jp285636
BibTeX
@article{Carlini2024,
author = {Carlini, Nicholas A and Harber, Matthew P and Fleenor, Bradley S},
title = {Acute effects of MitoQ on vascular endothelial function are influenced by cardiorespiratory fitness and baseline FMD in middle‐aged and older adults},
journal = {The Journal of Physiology},
year = {2024},
doi = {10.1113/jp285636}
}
EUVIMED